Literature DB >> 12021356

Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins.

Frederick A Dick1, Nicholas J Dyson.   

Abstract

A critical event in papillomavirus transformation of human cells is the inactivation of pRB by the E7 protein. E7, like many other viral oncoproteins, possesses a well-characterized LXCXE peptide motif that interacts with the pocket domain of pRB. Disruption of the LXCXE-binding cleft on pRB renders it resistant to E7 binding and inactivation. Such binding cleft mutants of pRB are capable of inducing a G(1) arrest in the human papillomavirus 18-transformed HeLa cell line. We show here that the efficient inactivation of pRB in HeLa cells does not simply depend on the integrity of the LXCXE-binding cleft. Multiple site-directed mutants that alter conserved surfaces of the pRB pocket domain cause HeLa cells to accumulate in G(1). We divide these mutants into two classes: those that can be bound by E7 and those that cannot. The E7 interacting mutants include changes in conserved residues that lie in a groove between the A and B halves of the pocket. Surprisingly, none of these mutants show a clear defect in any of the known mechanisms for pRB inactivation by E7. Analysis of mutants that are compromised for E7 binding reveals that this interaction depends on both the LXCXE-binding cleft and on a conserved group of lysines adjacent to the cleft. These basic amino acids on pRB define a discrete interaction point with E7. These residues most likely form ionic interactions with conserved acidic amino acids on E7 since a stable pRB/E7 interaction was restored when the lysine residues on pRB and the acidic residues on E7 were interchanged.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021356      PMCID: PMC136242          DOI: 10.1128/jvi.76.12.6224-6234.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function.

Authors:  T T Chen; J Y Wang
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.

Authors:  A M Helt; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

Authors:  S L Gonzalez; M Stremlau; X He; J R Basile; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Role of the LXCXE binding site in Rb function.

Authors:  A Dahiya; M R Gavin; R X Luo; D C Dean
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.

Authors:  E C Goodwin; L K Naeger; D E Breiding; E J Androphy; D DiMaio
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen.

Authors:  H Y Kim; B Y Ahn; Y Cho
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

Review 7.  Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes.

Authors:  H zur Hausen
Journal:  Semin Cancer Biol       Date:  1999-12       Impact factor: 15.707

8.  Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.

Authors:  J Wang; A Sampath; P Raychaudhuri; S Bagchi
Journal:  Oncogene       Date:  2001-08-02       Impact factor: 9.867

9.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.

Authors:  E C Goodwin; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

10.  Acetylation control of the retinoblastoma tumour-suppressor protein.

Authors:  H M Chan; M Krstic-Demonacos; L Smith; C Demonacos; N B La Thangue
Journal:  Nat Cell Biol       Date:  2001-07       Impact factor: 28.824

View more
  16 in total

1.  Clefts, grooves, and (small) pockets: the structure of the retinoblastoma tumor suppressor in complex with its cellular target E2F unveiled.

Authors:  Karl Munger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

2.  pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption.

Authors:  L A Seifried; S Talluri; M Cecchini; L M Julian; J S Mymryk; F A Dick
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

Review 3.  Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

Authors:  Peter Pelka; Jailal N G Ablack; Gregory J Fonseca; Ahmed F Yousef; Joe S Mymryk
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

Review 4.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

5.  Complete genomes and phylogenetic positions of bovine papillomavirus type 8 and a variant type from a European bison.

Authors:  Yoshimi Tomita; Ivan Literak; Tomoko Ogawa; Zhongri Jin; Hiroshi Shirasawa
Journal:  Virus Genes       Date:  2007-01-30       Impact factor: 2.332

6.  The retinoblastoma protein regulates pericentric heterochromatin.

Authors:  Christian E Isaac; Sarah M Francis; Alison L Martens; Lisa M Julian; Laurie A Seifried; Natalie Erdmann; Ulrich K Binné; Lea Harrington; Piotr Sicinski; Nathalie G Bérubé; Nicholas J Dyson; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

7.  Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis.

Authors:  Kwang-Jin Oh; Anna Kalinina; Srilata Bagchi
Journal:  Virology       Date:  2009-11-10       Impact factor: 3.616

8.  A cancer derived mutation in the retinoblastoma gene with a distinct defect for LXCXE dependent interactions.

Authors:  Shauna A Henley; Sarah M Francis; Jordan Demone; Peter Ainsworth; Frederick A Dick
Journal:  Cancer Cell Int       Date:  2010-03-18       Impact factor: 5.722

9.  Analysis of cell cycle position in mammalian cells.

Authors:  Matthew J Cecchini; Mehdi Amiri; Frederick A Dick
Journal:  J Vis Exp       Date:  2012-01-21       Impact factor: 1.355

10.  HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia.

Authors:  Oscar Peralta-Zaragoza; Jessica Deas; Claudia Gómez-Cerón; Wendy Argelia García-Suastegui; Geny Del Socorro Fierros-Zárate; Nadia Judith Jacobo-Herrera
Journal:  Obstet Gynecol Int       Date:  2013-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.